4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-18-004295
Options or other derivatives
- Chief Medical Officer acquired 7,699 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Culwell Kelly Chief Medical Officer | 2018-01-17 | Grant or award · Stock Option (right to buy) | +7,699 | 7,699 | D | ||
Loading xslF345X03/doc4.xml…